Prioritizing cervical cancer candidate genes using chaos game and fractal-based time series approach

T Mallikarjuna1, N B Thummadi2, Vaibhav Vindal1

  • 1Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad, 500046, India.

Insights

This study identifies key genes involved in cervical cancer progression using a novel fractal cross-correlation analysis. Six genes, including CDH2 and BRAF, show significant potential for future therapeutic strategies and experimental validation.

Area of Science:

  • Oncology
  • Bioinformatics
  • Genetics

Background:

  • Cervical cancer is a leading cause of death in women globally, necessitating improved therapeutic strategies.
  • Advancements in high-throughput technologies have identified numerous candidate genes for cervical cancer.
  • Prioritizing these candidate genes is crucial for developing effective treatments.

Purpose of the Study:

  • To prioritize candidate genes involved in cervical cancer progression using a fractal time series-based cross-correlations approach.
  • To identify novel genetic markers for cervical cancer through advanced bioinformatics analysis.
  • To provide a framework for experimental validation of prioritized candidate genes.

Main Methods:

  • Application of chaos game representation theory and two-dimensional multifractal detrended cross-correlations analysis.
  • Cross-correlation analysis between known and candidate cervical cancer genes.
  • Functional enrichment analysis (Gene Ontology and KEGG pathways) and survival analysis.

Main Results:

  • Identified 16 candidate genes exhibiting cross-correlation with known cancer genes.
  • Functional analysis revealed involvement in cell-cell junctions, cytoskeleton organization, and key signaling pathways (e.g., MAPK, PI3K-Akt).
  • Six genes (CDH2, PAIP1, BRAF, EPB41L3, OSMR, RUNX1) were prioritized based on survival analysis for their crucial role in tumor progression.

Conclusions:

  • The fractal time series-based cross-correlations approach is an efficient tool for prioritizing candidate genes in cervical cancer.
  • The prioritized genes represent promising targets for further experimental validation and potential therapeutic development.
  • This integrative approach offers a new pathway for analyzing nucleotide and protein sequences for various applications.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K